AZN:NYSE
AstraZeneca PLC (US)
US$ 165.41
arrow_downward
-0.74%(-1.24) Siku 1
US$ 165.41
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 16 Okt, 16:00:03 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AZN...
Fungua
US$ 166.97
Juu
US$ 167.18
Chini
US$ 164.36
Mtaji wa soko
259.57B
Wastani wa kiasi cha mauzo
2.97M
Kiasi cha mauzo ya hisa
3.35M
Gawio
1.95%
Mgawo wa faida wa kila robo mwaka
US$ 0.81
Tarehe ya kutojumuisha gawio
6 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
24.73
Juu kwa wiki 52
US$ 212.71
Chini kwa wiki 52
US$ 80.48
EPS
US$ 6.69
Beta
0.30
Hisa za wawekezaji
1.55B
Idadi ya wafanyakazi
elfu 96
Fungua
US$ 166.97
Juu
US$ 167.18
Chini
US$ 164.36
Mtaji wa soko
259.57B
Wastani wa kiasi cha mauzo
2.97M
Kiasi cha mauzo ya hisa
3.35M
Gawio
1.95%
Mgawo wa faida wa kila robo mwaka
US$ 0.81
Tarehe ya kutojumuisha gawio
6 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
24.73
Juu kwa wiki 52
US$ 212.71
Chini kwa wiki 52
US$ 80.48
EPS
US$ 6.69
Beta
0.30
Hisa za wawekezaji
1.55B
Idadi ya wafanyakazi
elfu 96
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 4 zilizopita
AstraZeneca stock: RBC keeps GBp 14,500 target for AstraZeneca stock
Yahoo Finance
·
saa 4 zilizopita
AstraZeneca’s Shares Have Fallen, but Is 14.6x Forward Earnings a Buying Opportunity?
Kalkine Media
·
saa 6 zilizopita
FTSE 100 AstraZeneca (LSE:AZN): Cancer Drugs Back Dividend
Zacks
·
saa 6 zilizopita
4 Breast Cancer Stocks to Watch During Breast Cancer Awareness Month
Wasifu
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
Kuhusu AstraZeneca PLC (US)
Afisa Mkuu Mtendaji (CEO)Pascal Soriot
Wafanyakazielfu 96.1
Lilianzishwa6 Apr 1999
Makao makuuCambridge, Cambridgeshire, Uingereza
Sekta-
Tovutiastrazeneca.com